ABCL vs EIX
Abcellera Biologics Inc (ABCL) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported ABCL revenue for 2024-12-31 was $28.8M. Net income was -$162.9M. Revenue was down 24.2% from 2023-12-31 to 2024-12-31. ABCL currently screens at market cap $1.12B.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
ABCL currently screens at market cap $1.12B. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the ABCL and EIX stock pages for the full models.
Not investment advice.